Patents Assigned to The Administrattors of the Tulane Educational Fund
  • Association between a novel human intracisternal A-type retroviral particle-type II (HIAP-II) and idiopathic CD4+ T-lymphocytopenia (ICL)
    Patent number: 5580772
    Abstract: The present invention relates to the discovery of a novel retroviral particle associated with idiopathic CD4+ T-lymphocytopenia (ICL). New methods of diagnosis and treatment of ICL, novel cell lines comprising the new retrovirus, assay systems that may be used in the development of antiretroviral pharmaceuticals, model systems for the study of ICL and other immune diseases including acquired immunodeficiency syndrome (AIDS), and a diagnostic kit are provided by the present invention.
    Type: Grant
    Filed: May 17, 1994
    Date of Patent: December 3, 1996
    Assignee: The Administrattors of the Tulane Educational Fund
    Inventor: Robert F. Garry, Jr.